Literature DB >> 35430415

Competition for shared downstream signaling molecules establishes indirect negative feedback between EGFR and EphA2.

Dongmyung Oh1, Zhongwen Chen2, Kabir H Biswas3, Funing Bai4, Hui Ting Ong4, Michael P Sheetz5, Jay T Groves6.   

Abstract

Cells sense a variety of extracellular growth factors and signaling molecules through numerous distinct receptor tyrosine kinases (RTKs) on the cell surface. In many cases, the same intracellular signaling molecules interact with more than one type of RTK. How signals from different RTKs retain the identity of the triggering receptor and how (or if) different receptors may synergize or compete remain largely unknown. Here we utilize an experimental strategy, combining microscale patterning and single-molecule imaging, to measure the competition between ephrin-A1:EphA2 and epidermal growth factor (EGF):EGF receptor (EGFR) ligand-receptor complexes for the shared downstream signaling molecules, Grb2 and SOS. The results reveal a distinct hierarchy, in which newly formed EGF:EGFR complexes outcompete ephrin-A1:EphA2 for Grb2 and SOS, revealing a type of negative crosstalk interaction fundamentally controlled by chemical mass action and protein copy number limitations.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35430415      PMCID: PMC9199353          DOI: 10.1016/j.bpj.2022.04.015

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   3.699


  49 in total

1.  Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade.

Authors:  Rebecca L Pratt; Michael S Kinch
Journal:  Oncogene       Date:  2002-10-31       Impact factor: 9.867

2.  Architecture of Eph receptor clusters.

Authors:  Juha P Himanen; Laila Yermekbayeva; Peter W Janes; John R Walker; Kai Xu; Lakmali Atapattu; Kanagalaghatta R Rajashankar; Anneloes Mensinga; Martin Lackmann; Dimitar B Nikolov; Sirano Dhe-Paganon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-26       Impact factor: 11.205

Review 3.  Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway.

Authors:  Richard J Orton; Oliver E Sturm; Vladislav Vyshemirsky; Muffy Calder; David R Gilbert; Walter Kolch
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

Review 4.  Protein modules and signalling networks.

Authors:  T Pawson
Journal:  Nature       Date:  1995-02-16       Impact factor: 49.962

5.  Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathway.

Authors:  Tujin Shi; Mario Niepel; Jason E McDermott; Yuqian Gao; Carrie D Nicora; William B Chrisler; Lye M Markillie; Vladislav A Petyuk; Richard D Smith; Karin D Rodland; Peter K Sorger; Wei-Jun Qian; H Steven Wiley
Journal:  Sci Signal       Date:  2016-07-12       Impact factor: 8.192

6.  Restriction of receptor movement alters cellular response: physical force sensing by EphA2.

Authors:  Khalid Salaita; Pradeep M Nair; Rebecca S Petit; Richard M Neve; Debopriya Das; Joe W Gray; Jay T Groves
Journal:  Science       Date:  2010-03-12       Impact factor: 47.728

7.  Micropatterning fluid lipid bilayers on solid supports.

Authors:  J T Groves; N Ulman; S G Boxer
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

Review 8.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

9.  EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

Authors:  D P Zelinski; N D Zantek; J C Stewart; A R Irizarry; M S Kinch
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

10.  One-way membrane trafficking of SOS in receptor-triggered Ras activation.

Authors:  Sune M Christensen; Hsiung-Lin Tu; Jesse E Jun; Steven Alvarez; Meredith G Triplet; Jeffrey S Iwig; Kamlesh K Yadav; Dafna Bar-Sagi; Jeroen P Roose; Jay T Groves
Journal:  Nat Struct Mol Biol       Date:  2016-08-08       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.